Amyloid-β42 is preferentially accumulated in muscle fibers of patients with sporadic inclusion-body myositis

Acta Neuropathologica

Volumn 117, Issue 5, 2009, Pages 569-574

  Vattemi, Gaetano ^a   Nogalska, Anna ^a   King Engel, W ^a   D'Agostino, Carla ^a   Checler, Frederic ^b   Askanas, Valerie ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

Amyloid ; Amyloid oligomers; Amyloid 40; Amyloid 42; Cytotoxicity; Inclusion body myositis

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; PEPTIDE FRAGMENT;

ARTICLE; BIOACCUMULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOTOXICITY; ELECTRON MICROSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOELECTRON MICROSCOPY; IMMUNOREACTIVITY; INCLUSION BODY MYOSITIS; MUSCLE BIOPSY; MUSCLE FIBRIL; NEUROPATHOLOGY; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; TISSUE HOMOGENATE; BIOPSY; CELL INCLUSION; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; SKELETAL MUSCLE; ULTRASTRUCTURE;

AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; BIOPSY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOHISTOCHEMISTRY; INCLUSION BODIES; MICROSCOPY, IMMUNOELECTRON; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; MYOSITIS, INCLUSION BODY; PEPTIDE FRAGMENTS;

EID: 64449088789     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00401-009-0511-6     Document Type: Article

References (36)

1. Askanas V, Engel WK, Alvarez RB (1992) Light-and electron microscopic localization of β-amyloid protein in muscle biopsies of patients with inclusion-body myositis. Am J Pathol 141:31-36
2. Askanas V, Alvarez RB, Engel WK (1993) Beta-amyloid precursor epitopes in muscle fibers of inclusion body myositis. Ann Neurol 34:551-560. doi: 10.1002/ana.410340408
3. Askanas V, Engel WK, Alvarez RB (1993) Enhanced detection of Congo-red positive amyloid deposits in muscle fibers of inclusion-body myositis and brain of Alzheimer's disease using fluorescence technique. Neurology 43:1265-1267
4. Askanas V, Engel WK (1998) Does overexpression of AβPP in aging muscle have a pathogenic role and relevance to Alzheimer's disease? Am J Pathol 153:1673-1677
5. Askanas V, Engel WK, Yang CC, Alvarez RB, Lee VM, Wisniewski T (1998) Light and electron microscopic immunolocalization of presenilin 1 in abnormal muscle fibers of patients with sporadic inclusion-body myositis and autosomal-recessive inclusion-body myopathy. Am J Pathol 152:889-895
6. Askanas V, Engel WK (2007) Inclusion-body myositis, a multifactorial muscle disease associated with aging: Current concepts of pathogenesis. Curr Opin Rheumatol 19:550-559. doi: 10.1097/BOR.0b013e3282efdc7c
7. Askanas V, Engel WK (2008) Inclusion-body myositis: Muscle-fiber molecular pathology and possible pathogenic significance of its similarity to Alzheimer's and Parkinson's disease brains. Acta Neuropathol 116:583-595. doi: 10.1007/s00401-008-0449-0
8. Barelli H, Lebeau A, Vizzavona J, Delaere P, Chevallier N, Drouot C et al (1997) Characterization of new polyclonal antibodies specific for 40 and 42 amino acid-long amyloid beta peptides: Their use to examine the cell biology of presenilins and the immunohistochemistry of sporadic Alzheimer's disease and cerebral amyloid angiopathy cases. Mol Med 3:695-707
9. Bitan G, Kirkitadze MD, Lomakin A, Vollers SS, Benedek GB, Teplow DB (2003) Amyloid beta -protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways. Proc Natl Acad Sci USA 100:330-335. doi: 10.1073/pnas.222681699
10. Y-Ru Chen, Glabe C (2006) Distinct early folding and aggregation properties of Alzheimer amyloid-β peptides Aβ40 and Aβ42. J Biol Chem 281:24414-24422. doi: 10.1074/jbc.M602363200
11. Chromy BA, Nowak RJ, Lambert MP, Viola KL, Chang L, Velasco PT et al (2003) Self-assembly of Abeta (1-42) into globular neurotoxins. Biochemistry 42:12749-12760. doi: 10.1021/bi030029q
12. El-Agnaf OM, Mahil DS, Patel BP, Austen BM (2000) Oligomerization and toxicity of beta-amyloid-42 implicated in Alzheimer's disease. Biochem Biophys Res Commun 273:1003-1007. doi: 10.1006/bbrc.2000.3051
13. Engel WK, Askanas V (2006) Inclusion-body myositis: Clinical, diagnostic, and pathologic aspects. Neurology 66:S20-S29. doi: 10.1212/ 01.wnl.0000192260.33106.bb
14. Fratta P, Engel WK, McFerrin J, Davies KJA, Lin SW, Askanas V (2005) Proteasome inhibition and aggresome formation in sporadic inclusion-body myositis and in amyloid-beta precursor protein-overexpressing cultured human muscle fibers. Am J Pathol 167:517-526
15. Glabe C (2001) Intracellular mechanisms of amyloid-accumulation and pathogenesis in Alzheimer's disease. J Mol Neurosci 17:137-145. doi: 10.1385/JMN:17:2:137
16. Gouras GK, Xu H, Jovanovic JH, Buxbaum JD, Wang R, Greengard P, Relkin NR, Gandy S (1998) Generation and regulation of beta-amyloid peptide variants by neurons. J Neurochem 71:1920-1925
17. Gouras GK, Tsai J, Naslund J, Vincent B, Edgar M, Checler F et al (2000) Intraneuronal Abeta42 accumulation in human brain. Am J Pathol 156:15-20
18. Greenfield JP, Tsai J, Gouras GK, Hai B, Thinakaran G, Checler F et al (1999) Endoplasmic reticulum and trans-Golgi network generate distinct populations of Alzheimer beta-amyloid peptides. Proc Natl Acad Sci USA 96:742-747. doi: 10.1073/pnas.96.2.742
19. Kitazawa M, Green KN, Caccamo A, LaFerla FM (2006) Genetically augmenting Abeta42 levels in skeletal muscle exacerbates inclusion body myositis-like pathology and motor deficits in transgenic mice. Am J Pathol 168:1986-1997. doi: 10.2353/ajpath.2006.051232
20. Marlow L, Cain M, Pappolla MA, Sambamurti K (2003) Beta-secretase processing of the Alzheimer's amyloid protein precursor (APP). J Mol Neurosci 20:233-239. doi: 10.1385/JMN:20:3:233
21. Masuda Y, Uemura S, Ohashi R, Nakanishi A, Takegoshi K, Shimizu T, Shirasawa T, Irie K (2008) Identification of physiological and toxic conformations in Abeta42 aggregates. ChemBioChem 10:287-295. doi: 10.1002/cbic.200800411
22. Mirabella M, Alvarez RB, Bilak M, Engel WK, Askanas V (1996) Difference in expression of phosphorylated tau epitopes between sporadic inclusion-body myositis and hereditary inclusion-body myopathies. J Neuropathol Exp Neurol 55:774-786. doi: 10.1097/00005072-199607000-00003
23. Needham M, Mastaglia FL (2007) Inclusion body myositis: Current pathogenetic concepts and diagnostic and therapeutic approaches. Lancet Neurol 6:620-631. doi: 10.1016/S1474-4422(07)70171-0
24. Nogalska A, Engel WK, McFerrin J, Kokame K, Komano H, Askanas V (2006) Homocysteine-induced endoplasmic reticulum protein (Herp) is up-regulated in sporadic inclusion-body myositis and in endoplasmic reticulum stress-induced cultured human muscle fibers. J Neurochem 96:1491-1499. doi: 10.1111/j.1471-4159.2006.03668.x
25. Oddo S, Caccamo A, Tseng B, Vasilevko V, Cribs DH et al (2008) Blocking Abeat42 accumumulation delays the onset and progression of tau pathology via the C terminus of heat shock protein70-interacting protein: A mechanistic link between Abeta and tau pathology. J Neurosci 28:12163-12175. doi: 10.1523/JNEUROSCI.2464-08.2008
26. Sarkozi E, Askanas V, Johnson SA, Engel WK, Alvarez RB (1993) Beta-Amyloid precursor protein mRNA is increased in inclusion-body myositis muscle. Neuroreport 4:815-818. doi: 10.1097/ 00001756-199306000-00055
27. Scheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N et al (1996) Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat Med 2:864-870. doi: 10.1038/nm0896-864
28. Serpell LC (2000) Alzheimer's amyloid fibrils: Structure and assembly. Biochim Biophys Acta 1502:16-30
29. Suh YH, Checler F (2002) Amyloid precursor protein, presenilins, and alpha-synuclein: Molecular pathogenesis and pharmacological applications in Alzheimer's disease. Pharm Rev 54:469-525. doi: 10.1124/pr.54.3.469
30. Vattemi G, Engel WK, McFerrin J, Buxbaum JD, Pastorino L, Askanas V (2001) Presence of BACE1 and BACE2 in muscle fibres of patients with sporadic inclusion-body myositis. Lancet 358:1962-1964. doi: 10.1016/ S0140-6736(01)06969-0
31. Vattemi G, Engel WK, McFerrin J, Pastorino L, Buxbaum JD, Askanas V (2003) BACE1 and BACE2 in pathologic and normal human muscle. Exp Neurol 179:150-158. doi: 10.1016/S0014-4886(02)00025-0
32. Vattemi G, Kefi M, Engel WK, Askanas V (2003) Nicastrin, a novel protein participating in amyloid-b production, is overexpressed in sporadic inclusion-body myositis muscle. Neurology 60:A315
33. Vattemi G, Engel WK, McFerrin J, Askanas V (2004) Endoplasmic reticulum stress and unfolded protein response in inclusion-body myositis muscle. Am J Pathol 164:1-7
34. Vetrivel KS, Thinakaran G (2006) Amyloidogenic processing of beta-amyloid precursor protein in intracellular compartments. Neurology 66:S69-S73. doi: 10.1212/01.wnl.0000192107.17175.39
35. Wojcik S, Engel WK, McFerrin J, Paciello O, Askanas V (2006) AbetaPP-overexpression and proteasome inhibition increase αB-crystallin in cultured human muscle: Relevance to inclusion-body myositis. Neuromuscul Disord 16:839-844. doi: 10.1016/ j.nmd.2006.08.009
36. Yanker BA, Lu T (2008) Amyloid β-protein toxicity and the pathogenesis of Alzheimer's disease. J Biol Chem doi: 10.1074/ jbc.R800018200